Inion mulls job cuts to curb spending
This article was originally published in Clinica
Finnish biodegradable medical implants developer Inion this week said it has embarked on a cost-reduction programme while it tries to obtain more financing. The London Stock Exchange-listed firm has initiated discussions with employees at its Tampere base as part of a "fair consultation" before deciding on whether to make job cuts.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.